Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.
Press releases published on October 1, 2025
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
CORAL GABLES, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for people …
Shoppers Plan to Spend More in 2026, but Loyalty Is Up for Grabs
BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Consumer wallets are loosening, but loyalty is no longer the driver of sales. The latest Q4 Ecommerce Pulse Report from Salsify and the Digital Shelf Institute (DSI) finds that just 39% of shoppers plan to spend …
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), today announced that the U.S. Food and Drug Administration (“FDA”) has issued a Complete …
Aeries Technology Delivers ~30% Faster Development Cycles Through AI-Enabled Engineering
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, today announced the successful completion of an AI-driven application …
Inriver Raises the Bar for Product Data Control with AI Breakthroughs and Platform Upgrades
Highlights: The release notably advances AI capabilities that are integrated directly into workflows. Embedded AI agents, including Inspire Generate and Translate, support automated enrichment, translation and data transformations, with human-in-the-loop …
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial
SYDNEY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet …
Sophos Launches Advisory Services to Deliver Proactive Cybersecurity Resilience
OXFORD, United Kingdom, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating cyberattacks, today announced the launch of Sophos Advisory Services, a suite of security testing services designed to identify …
Datanomix Launches Universal ERP Connector to Bridge the Gap Between Planning and Production
NASHUA, N.H., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Datanomix, the leader in Data-Powered Production™ intelligence for precision manufacturers, today announced the launch of its Universal ERP Connector—a simple, powerful way to connect any ERP system to the …
ESET Enhances its Basic Cybersecurity Awareness Training and Releases Free Resources for Cybersecurity Awareness Month
SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today released a new and improved version of its free ESET Basic Cybersecurity Awareness Training. The revamped Basic course introduces an immersive storyline, interactive …
Magnite To Unify Curation and Activation Within ClearLine
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ:MGNI), the largest independent sell-side advertising company, today announced the evolution of ClearLine, to unify curation and activation across the company’s premium omnichannel footprint. …
Avalyn Appoints Industry Veterans Jill Denning and Kimberley Cummings to Leadership
BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced two key leadership …
Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update
RA'ANANA, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (“Inspira” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced its financial results for the …
Fewer than half of enterprises are fully successful with network observability tools: New research from Enterprise Management Associates and BlueCat
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- BlueCat, the leading provider of Intelligent Network Operations solutions for AI-enabled networks, today announced the findings of a new report developed in collaboration with Enterprise Management Associates ( …
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate …
Starton Therapeutics to Participate in Panel at Longwood Healthcare Leaders Boston CEO, October 27-28, 2025
PARAMUS, N.J., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, announced today that Pedro Lichtinger, …
ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
MADRID and CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and European leader in epigenetics, today announced that the European Patent Office (EPO) has …
CorVista Health Appoints Guido Neels and Dino Trevisani to Board of Directors
Veteran MedTech leader Guido Neels joins CorVista, leveraging his experience as EW Healthcare Partners Operating Partner and former Guidant COO. Company founder Dino Trevisani returns to CorVista, bringing decades of global technology expertise from his …
COUR Pharma Secures FDA Orphan Drug Designation for CNP-106 in Generalized Myasthenia Gravis
CHICAGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced today the U.S. Food and Drug Administration (FDA) has …
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the acceptance of an abstract for …